Cargando…

MEK/ERK addiction in CNL/aCML

Detalles Bibliográficos
Autores principales:	Kesarwani, Meenu, Kincaid, Zachary, Azam, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725083/ https://www.ncbi.nlm.nih.gov/pubmed/29245892 http://dx.doi.org/10.18632/oncotarget.22283

Ejemplares similares

CNL and aCML are prognostically distinct: a large National Cancer Database analysis
por: Tremblay, Douglas, et al.
Publicado: (2023)

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
por: Carreño-Tarragona, Gonzalo, et al.
Publicado: (2022)

A rare case of aCML associated with CNS involvement and with aggressive clinical course
por: Lame, Dorela, et al.
Publicado: (2023)

Registro radioactivo neutrón compensado (CNL)
por: Hernández Hernández, Ricardo
Publicado: (1984)

EE-ACML: Energy-Efficient Adiabatic CMOS/MTJ Logic for CPA-Resistant IoT Devices †
por: Kahleifeh, Zachary, et al.
Publicado: (2021)

Momelotinib is a highly potent inhibitor of FLT3-mutant AML
por: Azhar, Mohammad, et al.
Publicado: (2022)

CNL Disease Resistance Genes in Soybean and Their Evolutionary Divergence
por: Nepal, Madhav P, et al.
Publicado: (2015)

c-Fos and Dusp1 confer non-oncogene addiction in BCR-ABL induced leukemia
por: Kesarwani, Meenu, et al.
Publicado: (2017)

Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML
por: Azhar, Mohammad, et al.
Publicado: (2022)

MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression
por: Farnsworth, Dylan A., et al.
Publicado: (2022)

PB2249: ATYPICAL CHRONIC MYELOID LEUKEMIA (ACML) AND AUTOIMMUNE DISEASE: REPORT OF TWO CASES.
por: Tatarelli, Caterina, et al.
Publicado: (2023)

Enhanced MAPK signaling is essential for CSF3R induced leukemia
por: Rohrabaugh, Sara, et al.
Publicado: (2016)

New concepts for CML clonality
por: Khorashad, Jamshid S., et al.
Publicado: (2013)

Eradication of CML stem cells
por: Carter, Bing Z., et al.
Publicado: (2016)

Chronic Myelogenous Leukemia (CML) in the elderly
por: Balducci, Lodovico, et al.
Publicado: (2014)

Cobll1: A new player in CML
por: Kim, Hongtae, et al.
Publicado: (2017)

Targeting substrate-site in Jak2 kinase prevents emergence of genetic resistance
por: Kesarwani, Meenu, et al.
Publicado: (2015)

Data on the genome-wide identification of CNL R-genes in Setaria italica (L.) P. Beauv.
por: Andersen, Ethan J., et al.
Publicado: (2017)

Molecular response prediction in CML: novel ideas?
por: Wolf, Dominik, et al.
Publicado: (2017)

Cytogenetic alterations in CML: not all created equal
por: Gong, Zimu, et al.
Publicado: (2018)

The expanding CML treatment landscape: an introspective commentary
por: Lipton, Jeffrey H.
Publicado: (2023)

Kinase Inhibitor Therapy in CML: It's What's Inside That Counts
por: Eide, Christopher A., et al.
Publicado: (2013)

ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy
por: Aceves-Luquero, Clara I., et al.
Publicado: (2009)

Impact of the front-of-pack 5-colour nutrition label (5-CNL) on the nutritional quality of purchases: an experimental study
por: Julia, Chantal, et al.
Publicado: (2016)

CNL–Clitocybe nebularis Lectin—The Fungal GalNAcβ1-4GlcNAc-Binding Lectin
por: Sabotič, Jerica, et al.
Publicado: (2019)

Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm
por: Walia, Anushka, et al.
Publicado: (2023)

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020)

The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
por: Thomas, Kubin, et al.
Publicado: (2020)

The MEK5/ERK5 Pathway in Health and Disease
por: Paudel, Rupesh, et al.
Publicado: (2021)

Comparative genomic and transcriptomic analysis of selected fatty acid biosynthesis genes and CNL disease resistance genes in oil palm
por: Rosli, Rozana, et al.
Publicado: (2018)

Cotton CC-NBS-LRR Gene GbCNL130 Confers Resistance to Verticillium Wilt Across Different Species
por: Li, Tinggang, et al.
Publicado: (2021)

MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation
por: Zhao, W, et al.
Publicado: (2013)

ERK1b, a 46‐kDa ERK isoform that is differentially regulated by MEK
por: Yung, Yuval, et al.
Publicado: (2022)

MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK–ERK Signaling
por: Evans, Catherine, et al.
Publicado: (2013)

“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
por: Cseh, Botond, et al.
Publicado: (2014)

The MEK/ERK Pathway Promotes NOTCH Signalling in Pancreatic Cancer Cells
por: Tremblay, Isabelle, et al.
Publicado: (2013)

RNA sequencing analysis to demonstrate Erk dependent and independent functions of Mek
por: Liu, Chang, et al.
Publicado: (2015)

Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2018)

PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC
por: Davis, Thomas B., et al.
Publicado: (2019)

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
por: Degirmenci, Ufuk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v30229un0rhkpnj4lav0690vss